 | $9.97 Million in Sales Expected for IDEAYA Biosciences, Inc. (NASDAQ:IDYA) This Quarter
americanbankingnews.com - May 5 at 5:26 AM |
| IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Down to $20.73
americanbankingnews.com - May 4 at 12:48 PM |
| IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Expected to Announce Earnings of -$0.28 Per Share
americanbankingnews.com - May 3 at 6:08 AM |
| IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - April 30 at 12:48 PM |
| HC Wainwright Raises IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $35.00
americanbankingnews.com - April 26 at 9:00 AM |
| IDEAYA Biosciences (NASDAQ:IDYA) Price Target Increased to $38.00 by Analysts at Roth Capital
americanbankingnews.com - April 22 at 12:08 PM |
| IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up Following Analyst Upgrade
americanbankingnews.com - April 19 at 10:32 AM |
 | 2 Biotech Start-Ups Are Searching for Cancer’s Hidden Weaknesses. What to Know.
finance.yahoo.com - April 18 at 11:33 PM |
| IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $31.00 at Roth Capital
americanbankingnews.com - April 17 at 4:08 PM |
| IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $34.00
americanbankingnews.com - April 17 at 3:08 PM |
|
| Analysts Expect IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Will Post Earnings of -$0.24 Per Share
americanbankingnews.com - April 17 at 3:58 AM |
| IDEAYA Reports Darovasertib (IDE196) Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Combination in Metastatic Uveal Melanoma
finance.yahoo.com - April 16 at 8:30 AM |
| IDEAYA Announces Investor Day Webcast to Review Clinical Data from Phase 1/2 Trial of Darovasertib (IDE196) Monotherapy and Combination with Binimetinib in Metastatic Uveal Melanoma
finance.yahoo.com - April 15 at 7:15 PM |
| IDEAYA Announces Dosing of First Patient of MAT2A Inhibitor IDE397 in Phase 1 Clinical Trial Evaluating MTAP-Deletion Solid Tumors
finance.yahoo.com - April 15 at 9:13 AM |
| IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up to $17.76
americanbankingnews.com - April 13 at 11:10 AM |
| IDEAYA Posts Better-Than-Feared Quarterly Loss, Sales Top Estimates
finance.yahoo.com - March 23 at 1:09 PM |
| IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 23 at 8:08 AM |
| IDEAYA Announces Presentations at AACR Annual Meeting 2021 for Synthetic Lethality Programs IDE397 and PARG, and Kinase Inhibitor IDE196
finance.yahoo.com - March 11 at 9:06 AM |
| IDEAYA to Participate in Upcoming March 2021 Investor Relations Events
finance.yahoo.com - March 9 at 8:34 AM |
| Announcing: IDEAYA Biosciences (NASDAQ:IDYA) Stock Increased An Energizing 178% In The Last Year
finance.yahoo.com - February 15 at 9:55 AM |
| IDEAYA Announces IDE397 IND Clearance by U.S. FDA to Initiate Phase 1 and Appointment of Matthew Maurer, M.D., as Vice President, Head of Clinical Oncology and Medical Affairs
finance.yahoo.com - February 8 at 10:09 AM |
| IDEAYA to Participate in Upcoming February 2021 Investor Relations Events
finance.yahoo.com - February 1 at 9:46 AM |
| Spelman College and IDEAYA Biosciences Announce Partnership for Professional Development of the Next Generation of Female African American Leaders in the Biotechnology Industry
finance.yahoo.com - January 19 at 3:39 PM |
| IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U.S. FDA
finance.yahoo.com - January 11 at 8:15 AM |
| IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Crizotinib, a cMET Inhibitor
finance.yahoo.com - January 5 at 9:08 AM |
| IDEAYA Biosciences Announces Addition to NASDAQ Biotechnology Index
finance.yahoo.com - December 14 at 8:32 AM |
| Is IDYA A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 10:38 PM |
 | IDEAYA Bio: New GSK Partnership, $3B In Potential Cash Milestones, And 2 Key Therapeutics Advancing Rapidly, 34% Upside
seekingalpha.com - December 11 at 2:36 AM |
|
| IDEAYA Biosciences (IDYA) Jumps: Stock Rises 8.2%
finance.yahoo.com - December 8 at 1:50 PM |
 | Analysts Just Published A Bright New Outlook For IDEAYA Biosciences, Inc.'s (NASDAQ:IDYA)
nasdaq.com - November 18 at 8:39 AM |
| Industry Analysts Just Upgraded Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Forecasts By 95%
finance.yahoo.com - November 17 at 9:22 AM |
| IDEAYA Biosciences, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
nasdaq.com - November 15 at 1:43 PM |
| Results: IDEAYA Biosciences, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts
finance.yahoo.com - November 15 at 1:43 PM |
| IDEAYA Biosciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 12 at 10:07 AM |
 | IDEAYA to Participate in Upcoming November 2020 Investor Relations Events
markets.businessinsider.com - November 2 at 8:02 AM |
 | IDEAYA Biosciences Inc.
barrons.com - October 28 at 4:15 PM |
| IDEAYA Biosciences, Inc. Common Stock (IDYA)
nasdaq.com - October 22 at 7:11 PM |
| Ideaya inks research pact for Synthetic Lethal cancer platform
seekingalpha.com - October 22 at 2:10 PM |
| IDEAYA Announces Partnership With The Broad Institute And Advancement Of Synthetic Lethality Programs And Platform
finance.yahoo.com - October 22 at 9:10 AM |
| IDEAYA Biosciences Inc Registered Shs Outperform
markets.businessinsider.com - October 9 at 8:39 AM |
 | Why Ideaya Biosciences Is Trading Higher Today
benzinga.com - October 8 at 2:01 PM |
| IDEAYA to evaluate IDE196+Pfizer's crizotinib combo in solid tumors harboring GNAQ/11 mutations
seekingalpha.com - September 24 at 7:50 AM |
| Ideaya and Pfizer to test doublet therapy in certain solid tumors
seekingalpha.com - September 24 at 7:50 AM |
| IDEAYA Expands Clinical Trial Collaboration, Supply Agreement With Pfizer - Quick Facts
nasdaq.com - September 24 at 7:50 AM |
| What Kind Of Shareholders Hold The Majority In IDEAYA Biosciences, Inc.'s (NASDAQ:IDYA) Shares?
finance.yahoo.com - August 19 at 5:39 PM |
| What Kind Of Shareholders Hold The Majority In IDEAYA Biosciences, Inc.'s (NASDAQ:IDYA) Shares?
finance.yahoo.com - August 19 at 5:39 PM |
| IDEAYA Biosciences EPS misses by $2.83
seekingalpha.com - August 12 at 8:42 AM |
| IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 12 at 8:42 AM |
| IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 12 at 8:42 AM |
| Is a Surprise Coming for IDEAYA Biosciences (IDYA) This Earnings Season?
finance.yahoo.com - August 7 at 12:47 PM |
